Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Pfizer files lung cancer drug in the EU, US

pharmatimesJuly 18, 2018

Tag: Pfizer , NSCLC , Dacomitinib , Phase III ARCHER 1050

PharmaSources Customer Service